Cytotoxic T cells in chronic idiopathic neutropenia express restricted antigen receptors

References

• Papadaki HA, Palmblad J, Eliopoulos GD. Non-immune chronic idiopathic neutropenia of adult: an overview. Eur J Haematol. 2001;67:35–44.
   PubMed Web of Science ®Google Scholar
• Dale DC, Neutrophil disorders: bening, quantitative abnormalities of neutriphils. New York: McGraw-Hill Publishing Company; 1991.
   Google Scholar
• Papadaki HA, Pontikoglou C. Pathophysiologic mechanisms, clinical features and treatment of idiopathic neutropenia. Expert Rev Hematol. 2008;1:217–229.
   PubMed Web of Science ®Google Scholar
• Palmblad J, Papadaki HA. Chronic idiopathic neutropenias and severe congenital neutropenia. Curr Opin Hematol. 2008;15:8–14.
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Eliopoulos AG, Kosteas T, et al. Impaired granulocytopoiesis in patients with chronic idiopathic neutropenia is associated with increased apoptosis of bone marrow myeloid progenitor cells. Blood. 2003;101:2591–2600.
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Giouremou K, Eliopoulos GD. Low frequency of myeloid progenitor cells in chronic idiopathic neutropenia of adults may be related to increased production of TGF-beta1 by bone marrow stromal cells. Eur J Haematol. 1999;63:154–162.
   PubMed Web of Science ®Google Scholar
• Papadaki HA, Stamatopoulos K, Damianaki A, et al. Activated T-lymphocytes with myelosuppressive properties in patients with chronic idiopathic neutropenia. Br J Haematol. 2005;128:863–876.
   PubMed Web of Science ®Google Scholar
• Spanoudakis M, Koutala H, Ximeri M, et al. T-cell receptor Vβ repertoire analysis in patients with chronic idiopathic neutropenia demonstrates the presence of aberrant T-cell expansions. Clin Immunol. 2010;137:384–395.
   PubMed Web of Science ®Google Scholar
• van Dongen JJ, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia. 2003;17:2257–2317.
   PubMed Web of Science ®Google Scholar
• Giudicelli V, Brochet X, Lefranc MP. IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequences. Cold Spring Harb Protoc. 2011;2011:695–715.
   PubMedGoogle Scholar
• O'Keefe CL, Plasilova M, Wlodarski M, et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol. 2004;172:1960–1969.
   PubMed Web of Science ®Google Scholar
• Clemente MJ, Wlodarski MW, Makishima H, et al. Clonal drift demonstrates unexpected dynamics of the T-cell repertoire in T-large granular lymphocyte leukemia. Blood. 2011;118:4384–4393.
   PubMed Web of Science ®Google Scholar
• Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120:3048–3057.
   PubMed Web of Science ®Google Scholar
• Papalexandri A, Stalika E, Iskas M, et al. Molecular evidence for repertoire skewing of T large granular lymphocyte proliferation after allogeneic hematopoietic SCT: report of two cases. Bone Marrow Transplant. 2013;48:1260–1261.
   PubMed Web of Science ®Google Scholar
• Stalika E, Papalexandri A, Iskas M, et al. Familial CD3+ T large granular lymphocyte leukemia: evidence that genetic predisposition and antigen selection promote clonal cytotoxic T-cell responses. Leuk Lymphoma. 2014;55:1781–1787.
   PubMed Web of Science ®Google Scholar
• Krzywinski M, Schein J, Birol I, et al. Circos: an information aesthetic for comparative genomics. Genome Res. 2009;19:1639–1645.
   PubMed Web of Science ®Google Scholar
• Wlodarski MW, Nearman Z, Jiang Y, et al. Clonal predominance of CD8(+) T cells in patients with unexplained neutropenia. Exp Hematol. 2008;36:293–300.
   PubMed Web of Science ®Google Scholar
• Germain RN, Stefanova I. The dynamics of T cell receptor signaling: complex orchestration and the key roles of tempo and cooperation. Annu Rev Immunol. 1999;17:467–522.
   PubMed Web of Science ®Google Scholar
• Contini P, Ghio M, Poggi A, et al. Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol. 2003;33:125–134.
   PubMed Web of Science ®Google Scholar
• Delon J, Gregoire C, Malissen B, et al. CD8 expression allows T cell signaling by monomeric peptide-MHC complexes. Immunity. 1998;9:467–473.
   PubMed Web of Science ®Google Scholar
• Koskela HL, Eldfors S, Ellonen P, et al. Somatic STAT3 mutations in large granular lymphocytic leukemia. N Engl J Med. 2012;366:1905–1913.
   PubMed Web of Science ®Google Scholar
• Jerez A, Clemente MJ, Makishima H, et al. STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients. Blood. 2013;122:2453–2459.
   PubMed Web of Science ®Google Scholar
• Arstila TP, Casrouge A, Baron V, et al. A direct estimate of the human alphabeta T cell receptor diversity. Science. 1999;286:958–961.
   PubMed Web of Science ®Google Scholar
• Nikolich-Zugich J, Slifka MK, Messaoudi I. The many important facets of T-cell repertoire diversity. Nat Rev Immunol. 2004;4:123–132.
   PubMed Web of Science ®Google Scholar
• Stalika E, Papalexandri A, Kannelis G, et al. Transient monoclonal CD3+ T large granular lymphocyte proliferation in a case of mantle cell lymphoma with Rituximab-associated late onset neutropenia. Hematol Oncol. 2011;29:144–146.
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Anagnostopoulos A, et al. Rituximab-associated immune myelopathy. Blood. 2003;102:1557–1558.
   PubMed Web of Science ®Google Scholar
• Papadaki T, Stamatopoulos K, Stavroyianni N, et al. Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases. Leuk Res. 2002;26:597–600.
   PubMed Web of Science ®Google Scholar
• Stamatopoulos K, Papadaki T, Pontikoglou C, et al. Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia. Leukemia. 2008;22:1446–1449.
   PubMed Web of Science ®Google Scholar
• Miles JJ, Elhassen D, Borg NA, et al. CTL recognition of a bulged viral peptide involves biased TCR selection. J Immunol. 2005;175:3826–3834.
   PubMed Web of Science ®Google Scholar
• Tynan FE, Reid HH, Kjer-Nielsen L, et al. A T cell receptor flattens a bulged antigenic peptide presented by a major histocompatibility complex class I molecule. Nat Immunol. 2007;8:268–276.
   PubMed Web of Science ®Google Scholar